Director, Global Regulatory Affairs CMC, Gene Therapy @ (February 2016 - June 2019)
Director, Technical Development @ (July 2013 - March 2016)
Associate Director, Analytical Development @ (January 2010 - August 2013)
Senior Scientist, Analytical Development-CMC Lead @ (January 2007 - February 2010)
Senior Scientist @ (June 1998 - December 2006)
Graduate Student @ (January 1993 - January 1998)
Graduate Student @ (January 1993 - January 1998)
Student @ (January 1989 - January 1993)
Student @ (January 1989 - January 1993)
Andy Weiskopf Education
Northeastern University
Doctor Of Philosophy (Chemistry)
1993-1998
Brandeis University
Bachelor Of Arts (Chemistry)
1989-1993
Andy Weiskopf Skills
LC-MS
Technology Transfer
GMP
Purification
Chromatography
Pharmaceutical Industry
Biotechnology
FDA
Biopharmaceuticals
LIMS
Lifesciences
Monoclonal Antibodies
Protein Chemistry
Drug Discovery
GLP
Assay Development
HPLC
Analytical Chemistry
Drug Development
Validation
CMC
Biochemistry
Antibodies
Mass Spectrometry
Sop
Regulatory Submissions
Formulation
Protein Purification
Clinical Development
IND
Life Sciences
Lc Ms
Training
Social Media
Public Speaking
Gene Therapy
Regulatory Filings
Regulatory Policy
Regulatory Interactions
Product Development
CMC Regulatory Affairs
Andy Weiskopf Summary
Andy Weiskopf, based in Cambridge, MA, US, is currently a Vice President, CMC Regulatory Affairs at Sana Biotechnology, Inc.. Andy Weiskopf brings experience from previous roles at Biogen. Andy Weiskopf holds a 1993 - 1998 Doctor Of Philosophy in Chemistry @ Northeastern University. With a robust skill set that includes LC-MS, Technology Transfer, GMP, Purification, Chromatography and more. Andy Weiskopf has 1 emails on RocketReach.
Looking for a different Andy Weiskopf?
Find contact details for 700 million professionals.